Document is current
Any future updates will be listed below
-
Authors
de Jong, Bas T. https://orcid.org/0009-0007-3939-9935
Eleveld, Douglas J. https://orcid.org/0000-0002-0340-3847
Mason, Keira P. https://orcid.org/0000-0002-9375-7816
Struys, Michel M. R. F. https://orcid.org/0000-0003-0421-536X
- License Information
-
More Information
Article History
Accepted: 6 July 2025
First Online: 21 July 2025
Declarations
:
: This work was solely supported by departmental funding.
: Bas T. de Jong has no conflicts of interest that are directly relevant to the content of this article. For departmental conflicts of interest, see MMRFS. Douglas J. Eleveld has no conflicts of interest that are directly relevant to the content of this article. For departmental conflicts of interest, see MMRFS. Keira P. Mason: her research group has received funding for sponsor-initiated research from Eagle Pharmaceuticals Inc., Woodcliff Lake, NJ, USA. Michel M.R.F. Struys: his research group/department received (over the last 3 years) research grants and consultancy fees from Masimo (Irvine, CA, USA), Becton Dickinson (Eysins, Switzerland), Fresenius-Kabi (Bad Homburg, Germany), Paion (Aachen, Germany), Medcaptain Europe (Andelst, The Netherlands), Baxter (Chicago, IL, USA), Eagle Pharmaceuticals Inc. (Woodcliff, NJ, USA) and HanaPharm (Seoul, Republic of Korea). He receives royalties on intellectual property from Demed Medical (Sinaai, Belgium) and Ghent University (Ghent, Belgium).
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: BTdJ: literature search, conceptualization, and writing. DJE: writing sections, manuscript correction. KPM: writing sections, literature search, manuscript correction. MMRFS: conceptualization, writing sections, manuscript correction.
